Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.893 EUR 1.42%
Market Cap: 605.8m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Intrinsic Value

The intrinsic value of one PHARM stock under the Base Case scenario is 1.198 EUR. Compared to the current market price of 0.893 EUR, Pharming Group NV is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHARM Intrinsic Value
1.198 EUR
Undervaluation 25%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Pharming Group NV

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PHARM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PHARM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about PHARM?
Bearish
Neutral
Bullish

Fundamental Analysis

0.893 EUR
+1.42%
+1.42%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Pharming Group NV
NL
Biotechnology
Market Cap
605.9m EUR
IPO
Jul 2, 1998
Employees
321
Netherlands
Market Cap
605.9m EUR
Industry
Biotechnology
IPO
Jul 2, 1998
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Pharming Group NV

Provide an overview of the primary business activities
of Pharming Group NV.

What unique competitive advantages
does Pharming Group NV hold over its rivals?

What risks and challenges
does Pharming Group NV face in the near future?

Has there been any significant insider trading activity
in Pharming Group NV recently?

Summarize the latest earnings call
of Pharming Group NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharming Group NV.

Provide P/S
for Pharming Group NV.

Provide P/E
for Pharming Group NV.

Provide P/OCF
for Pharming Group NV.

Provide P/FCFE
for Pharming Group NV.

Provide P/B
for Pharming Group NV.

Provide EV/S
for Pharming Group NV.

Provide EV/GP
for Pharming Group NV.

Provide EV/EBITDA
for Pharming Group NV.

Provide EV/EBIT
for Pharming Group NV.

Provide EV/OCF
for Pharming Group NV.

Provide EV/FCFF
for Pharming Group NV.

Provide EV/IC
for Pharming Group NV.

Show me price targets
for Pharming Group NV made by professional analysts.

What are the Revenue projections
for Pharming Group NV?

How accurate were the past Revenue estimates
for Pharming Group NV?

What are the Net Income projections
for Pharming Group NV?

How accurate were the past Net Income estimates
for Pharming Group NV?

What are the EPS projections
for Pharming Group NV?

How accurate were the past EPS estimates
for Pharming Group NV?

What are the EBIT projections
for Pharming Group NV?

How accurate were the past EBIT estimates
for Pharming Group NV?

Compare the revenue forecasts
for Pharming Group NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharming Group NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharming Group NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharming Group NV compared to its peers.

Compare the P/E ratios
of Pharming Group NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharming Group NV with its peers.

Analyze the financial leverage
of Pharming Group NV compared to its main competitors.

Show all profitability ratios
for Pharming Group NV.

Provide ROE
for Pharming Group NV.

Provide ROA
for Pharming Group NV.

Provide ROIC
for Pharming Group NV.

Provide ROCE
for Pharming Group NV.

Provide Gross Margin
for Pharming Group NV.

Provide Operating Margin
for Pharming Group NV.

Provide Net Margin
for Pharming Group NV.

Provide FCF Margin
for Pharming Group NV.

Show all solvency ratios
for Pharming Group NV.

Provide D/E Ratio
for Pharming Group NV.

Provide D/A Ratio
for Pharming Group NV.

Provide Interest Coverage Ratio
for Pharming Group NV.

Provide Altman Z-Score Ratio
for Pharming Group NV.

Provide Quick Ratio
for Pharming Group NV.

Provide Current Ratio
for Pharming Group NV.

Provide Cash Ratio
for Pharming Group NV.

What is the historical Revenue growth
over the last 5 years for Pharming Group NV?

What is the historical Net Income growth
over the last 5 years for Pharming Group NV?

What is the current Free Cash Flow
of Pharming Group NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharming Group NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharming Group NV

Current Assets 282.2m
Cash & Short-Term Investments 171.8m
Receivables 48.2m
Other Current Assets 62.2m
Non-Current Assets 143.3m
Long-Term Investments 7.2m
PP&E 30.7m
Intangibles 67.1m
Other Non-Current Assets 38.4m
Current Liabilities 79.8m
Accounts Payable 72.6m
Other Current Liabilities 7.2m
Non-Current Liabilities 119.9m
Long-Term Debt 119.9m
Efficiency

Earnings Waterfall
Pharming Group NV

Revenue
285.7m USD
Cost of Revenue
-30.3m USD
Gross Profit
255.4m USD
Operating Expenses
-269.7m USD
Operating Income
-14.3m USD
Other Expenses
-3.6m USD
Net Income
-17.8m USD

Free Cash Flow Analysis
Pharming Group NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PHARM Profitability Score
Profitability Due Diligence

Pharming Group NV's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Free Cash Flow
43/100
Profitability
Score

Pharming Group NV's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

PHARM Solvency Score
Solvency Due Diligence

Pharming Group NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
47/100
Solvency
Score

Pharming Group NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHARM Price Targets Summary
Pharming Group NV

There are no price targets for PHARM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PHARM?

Click here to dive deeper.

Dividends

Pharming Group NV
does not pay dividends
Shareholder Yield

Current shareholder yield for PHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PHARM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one PHARM stock?

The intrinsic value of one PHARM stock under the Base Case scenario is 1.198 EUR.

Is PHARM stock undervalued or overvalued?

Compared to the current market price of 0.893 EUR, Pharming Group NV is Undervalued by 25%.

Back to Top